PULMONARYHYPERTENSIONRN.COM: Keyword Density Checker

Total words: 3380 | 2-word phrases: 908 | 3-word phrases: 1005 | 4-word phrases: 1051

PAGE INFO

Title	Try to keep the title under 60 characters (68 characters) Pulmonary Hypertension Educational Information by Dr. Jeremy Feldman
Description	Try to keep the meta description between 50 - 160 characters (137 characters) Information for patients living with pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH). Edited by a nurse and doctor.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (25 characters) Pulmonary Hypertension RN

#	Keyword	Frequency	Density
1	pulmonary arterial hypertension	6	0.60%
2	by dr jeremy	6	0.60%
3	dr jeremy feldman	5	0.50%
4	congenital heart disease	4	0.40%
5	right heart catheterization	3	0.30%
6	is pulmonary hypertension?	3	0.30%
7	to treat pah	3	0.30%
8	causes of pulmonary	3	0.30%
9	children with pah	2	0.20%
10	signaling in the	2	0.20%
11	swelling children with	2	0.20%
12	hand swelling children	2	0.20%
13	of rodatristat ethyl	2	0.20%
14	the pulmonary hypertension	2	0.20%
15	research life expectancyprognosis	2	0.20%
16	for pulmonary hypertension	2	0.20%
17	with pulmonary arterial	2	0.20%
18	for pulmonary hypertension?	2	0.20%
19	pulmonary hypertension centers	2	0.20%
20	hypertension hand swelling	2	0.20%
21	the disease and	2	0.20%
22	progression of the	2	0.20%
23	in memoriam greg ahearn	2	0.20%
24	pulmonary hypertension rn	2	0.20%
25	care centers faq	2	0.20%
26	of pulmonary hypertension	2	0.20%
27	treatment for pulmonary	2	0.20%
28	sotatercept winrevair approved	2	0.20%
29	what is pulmonary	2	0.20%
30	memoriam greg ahearn md	2	0.20%

#	Keyword	Frequency	Density
1	by dr jeremy feldman	4	0.38%
2	treatment for pulmonary hypertension?	2	0.19%
3	in memoriam greg ahearn md	2	0.19%
4	treatment for pulmonary hypertension	2	0.19%
5	swelling children with pah	2	0.19%
6	hypertension causes of pulmonary	2	0.19%
7	hand swelling children with	2	0.19%
8	hypertension hand swelling children	2	0.19%
9	2023 enzyvant now sumitomo	1	0.10%
10	enzyvant now sumitomo pharma	1	0.10%
11	america a subsidiary of	1	0.10%
12	a subsidiary of sumitomo	1	0.10%
13	subsidiary of sumitomo pharma	1	0.10%
14	of sumitomo pharma announced	1	0.10%
15	sumitomo pharma announced an	1	0.10%
16	in july 2023 enzyvant	1	0.10%
17	pharma announced an update	1	0.10%
18	announced an update on	1	0.10%
19	an update on their	1	0.10%
20	phase 2 elevate 2	1	0.10%
21	2 elevate 2 study	1	0.10%
22	elevate 2 study of	1	0.10%
23	2 study of rodatristat	1	0.10%
24	study of rodatristat ethyl	1	0.10%
25	of rodatristat ethyl for	1	0.10%
26	rodatristat ethyl for pah the	1	0.10%
27	ethyl for pah the phase	1	0.10%
28	july 2023 enzyvant now	1	0.10%
29	jeremy feldman in july	1	0.10%
30	feldman in july 2023	1	0.10%
31	the bmpr pathway you can	1	0.10%
32	in the activin pathway a	1	0.10%
33	major problem that contributes	1	0.10%
34	problem that contributes to	1	0.10%
35	that contributes to pah	1	0.10%
36	contributes to pah for	1	0.10%
37	to pah for most	1	0.10%
38	pah for most patients	1	0.10%
39	for most patients is	1	0.10%
40	most patients is impaired	1	0.10%

#	URL	Whois	Check